Aptevo Therapeutics Inc Earnings

The next earnings date for Aptevo Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Aptevo Therapeutics Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Aptevo Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/06/2025	Before Market	---	---
03/03/2025	Before Market	$-8.94	-15.35%
11/12/2024	Before Market	$-0.48	85.67%
08/08/2024	Before Market	$-1.67	74.50%
05/08/2024	Before Market	$-9.95	22.51%
03/05/2024	Before Market	$-6.16	65.85%
11/14/2023	Before Market	$-0.50	33.33%
08/10/2023	Before Market	$-1.23	-9.82%
05/11/2023	Before Market	$0.39	133.05%
03/30/2023	Before Market	$-0.95	37.91%
11/10/2022	Before Market	$-1.50	8.54%
08/11/2022	Before Market	$5.58	519.55%
05/12/2022	Before Market	$-1.55	-34.78%
03/24/2022	Before Market	$-1.27	1.55%
11/12/2021	Before Market	$-1.43	2.72%
08/12/2021	Before Market	$-1.75	12.50%
05/11/2021	Before Market	$-1.64	-197.04%
03/31/2021	Before Market	$-1.92	-57.38%
11/10/2020	After Market	$-2.10	-4.48%
08/14/2020	Before Market	$-2.10	-1.94%
05/13/2020	Before Market	$-2.84	-20.85%
03/25/2020	After Market	$-2.38	33.70%
11/07/2019	Before Market	$-3.22	4.17%
08/09/2019	Before Market	$-4.20	9.09%
05/09/2019	Before Market	$-6.16	0.00%
03/18/2019	Before Market	$-8.68	-16.20%
11/14/2018	After Market	$-7.84	2.37%
08/09/2018	Before Market	$-8.12	10.08%
05/10/2018	Before Market	$-8.82	-13.51%
03/13/2018	Before Market	$-6.44	-43.75%
11/09/2017	After Market	$24.78	-21.33%
08/10/2017	Before Market	$-7.42	13.11%
05/12/2017	Before Market	$-6.72	32.39%
03/31/2017	Before Market	$0.14	102.27%
11/18/2016	Before Market	$-11.06	-23.44%
08/26/2016	---	$-8.88	---

More About Aptevo Therapeutics Inc

Website

https://aptevotherapeutics.com

Country

USA

Full Time Employees

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

“Aptevo Therapeutics Inc Earnings” Can Refer to the Aptevo Therapeutics Inc Earnings Date

Some people say “Aptevo Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Aptevo Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Aptevo Therapeutics Inc Stock on the Earnings Date

If you own Aptevo Therapeutics Inc stock (APVO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Aptevo Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Aptevo Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Aptevo Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Aptevo Therapeutics Inc earnings or anything else related to the stock market.